Division of Rheumatology, Allergy, Immunology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Yawkey 2C, Boston, MA 02114, USA.
J Gen Intern Med. 2013 Jun;28(6):825-9. doi: 10.1007/s11606-013-2360-1. Epub 2013 Feb 13.
American College of Rheumatology guidelines recommend that patients taking glucocorticoids also take calcium and vitamin D supplements, regardless of the dose or intended duration of glucocorticoid use, to decrease their risk of glucocorticoid-induced osteopenia or osteoporosis (GIOP).
To increase the number of prescriptions made for calcium and vitamin D in patients who receive a prescription for glucocorticoids using an automated, computerized order set.
Pre-post test design.
A total of 1,041 outpatients receiving care at a single VA medical center. INTERVENTION/MAIN MEASURES: We developed an automated order set in which calcium and vitamin D were automatically co-ordered with glucocorticoid prescriptions of at least 2-week duration. We tested the impact of the order set by comparing the number of calcium and vitamin D prescriptions in patients taking glucocorticoids during a 12-month period before (T1) and after (T2) implementation. The automated order set could be modified by the treating physician, and it was not generated for patients with hypercalcemia.
A total of 535 patients during T1 and 506 patients during T2 had a glucocorticoid prescription of at least 2-week duration. The percent of co-prescriptions for calcium increased from 37 to 49% and vitamin D from 38 to 53% (both p < 0.0001) after the new automated order set was implemented.
Implementation of an automatic prescription for calcium and vitamin D supplementation modestly increases the number of patients on glucocorticoids who are prescribed calcium and vitamin D supplementation.
美国风湿病学会指南建议,无论糖皮质激素的剂量或预期使用时间如何,服用糖皮质激素的患者都应同时服用钙和维生素 D 补充剂,以降低糖皮质激素引起的骨质疏松症或骨质疏松症(GIOP)的风险。
通过使用自动化计算机医嘱单增加开具糖皮质激素处方患者的钙和维生素 D 处方数量。
前后测试设计。
在单个退伍军人事务医疗中心接受治疗的总共 1041 名门诊患者。
干预/主要措施:我们开发了一种自动化医嘱单,其中钙和维生素 D 与至少 2 周疗程的糖皮质激素处方自动联合开方。我们通过比较在实施前后(T1 和 T2)12 个月期间接受糖皮质激素治疗的患者中钙和维生素 D 处方的数量来测试医嘱单的影响。治疗医生可以修改自动医嘱单,且不会为血钙过高的患者生成医嘱单。
T1 期间有 535 例患者,T2 期间有 506 例患者接受了至少 2 周疗程的糖皮质激素处方。在新的自动化医嘱单实施后,钙的联合处方比例从 37%增加到 49%(均 p<0.0001),维生素 D 的联合处方比例从 38%增加到 53%(均 p<0.0001)。
实施钙和维生素 D 补充自动处方可适度增加接受糖皮质激素治疗的患者中开具钙和维生素 D 补充剂的患者数量。